Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment.

Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment. Gene Ther. 2006 Nov; 13(21):1503-11.

View in: PubMed

subject areas

Adenoviridae
Analysis of Variance
Antihypertensive Agents
Drug Therapy, Combination
Electrocardiography
Exercise Test
Female
Genetic Therapy
Genetic Vectors
Heart
Humans
Injections, Intramuscular
Male
Middle Aged
Myocardial Ischemia
Neovascularization, Physiologic
Safety
Tomography, Emission-Computed, Single-Photon
Transduction, Genetic
Treatment Outcome
Vascular Endothelial Growth Factor A

authors with profiles

Stephen Archer